back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-11-27 09:27 Tx date 2021-08-03 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,480,000 | ||
| Filed 2021-08-12 09:25 Tx date 2021-08-03 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-11-26 20:51 Tx date 2022-02-25 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,945
+3,887 vol $7.70 each |
1,643,887 | |
| Filed 2025-11-26 20:50 Tx date 2024-11-28 |
$BCT
BriaCell Therapeutics Corp. |
Lustig, Marc
3 - 10% Security Holder of Issuer, 4 - Director of Issuer
Holder: L5 Capital Inc. (Control or Direction)
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,203
+1,000 vol $1.20 each |
1,644,887 | |
| Filed 2025-10-02 16:21 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+5,000 vol |
5,000 | |
| Filed 2025-10-02 16:20 Tx date 2023-06-20 |
$BCT
BriaCell Therapeutics Corp. |
Gross, Jane
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:18 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
15,000 | |
| Filed 2025-10-02 16:16 Tx date 2020-12-01 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:14 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+5,000 vol |
5,000 | |
| Filed 2025-10-02 16:12 Tx date 2019-03-07 |
$BCT
BriaCell Therapeutics Corp. |
Taub, Rebecca Anne
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:10 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+100,000 vol |
100,000 | |
| Filed 2025-10-02 16:08 Tx date 2019-02-09 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-10-02 16:03 Tx date 2025-09-30 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
46 - Compensation for services
|
+15,000 vol |
15,000 | |
| Filed 2025-10-02 15:58 Tx date 2019-03-15 |
$BCT
BriaCell Therapeutics Corp. |
Embro-Pantalony, Vaughn
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-09-05 15:10 Tx date 2025-09-05 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-6,667 vol |
0 | |
| Filed 2025-09-05 15:09 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-10,192 vol |
1,132 | |
| Filed 2025-09-05 15:07 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Bondarenko, Jamieson
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-36,000 vol |
4,000 | |
| Filed 2025-09-02 11:23 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-34 vol |
4 | |
| Filed 2025-09-02 11:22 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
Schmieg, Martin
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-6,901 vol |
766 | |
| Filed 2025-08-28 11:02 Tx date 2025-08-25 |
$BCT
BriaCell Therapeutics Corp. |
WILLIAMS, WILLIAM
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-316,957 vol |
35,218 |